Kadmon (KDMN) Stock Price Up 7.5%
Kadmon Holdings Inc (NYSE:KDMN) rose 7.5% during mid-day trading on Friday . The company traded as high as $4.90 and last traded at $4.88. Approximately 2,510,528 shares changed hands during mid-day trading, an increase of 50% from the average daily volume of 1,675,908 shares. The stock had previously closed at $4.54.
KDMN has been the topic of a number of recent research reports. WBB Securities lowered Kadmon from a “hold” rating to a “sell” rating and set a $3.00 target price on the stock. in a research note on Monday, October 9th. Zacks Investment Research raised Kadmon from a “hold” rating to a “buy” rating and set a $4.25 target price on the stock in a research note on Friday, January 12th. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $25.00 target price on shares of Kadmon in a research note on Friday, November 17th. Two analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. Kadmon presently has a consensus rating of “Hold” and an average price target of $8.65.
Kadmon (NYSE:KDMN) last issued its quarterly earnings results on Thursday, November 9th. The company reported ($0.42) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.38) by ($0.04). The business had revenue of $2.28 million during the quarter, compared to the consensus estimate of $5.69 million. During the same quarter in the previous year, the company posted ($4.24) earnings per share. The firm’s revenue for the quarter was down 60.0% on a year-over-year basis. equities research analysts expect that Kadmon Holdings Inc will post -1.61 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Kadmon (KDMN) Stock Price Up 7.5%” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and international copyright laws. The correct version of this piece can be viewed at https://www.dailypolitical.com/2018/01/21/kadmon-kdmn-stock-price-up-7-5.html.
Kadmon Company Profile
Kadmon Holdings, Inc is an integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of various unmet medical needs. The Company is developing product candidates in a number of indications within autoimmune and fibrotic disease, oncology and genetic diseases.
Receive News & Ratings for Kadmon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kadmon and related companies with MarketBeat.com's FREE daily email newsletter.